| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3868657 | The Journal of Urology | 2012 | 6 Pages |
Abstract
Median prostate specific antigen doubling time decreases with time. This may influence the decision to offer secondary therapy to patients with biochemical recurrence sooner since initial prostate specific antigen doubling time is long and may not accurately reflect the biological nature of the disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
K. Clint Cary, Cynthia S. Johnson, Liang Cheng, Michael O. Koch,